AFCL Bioscience Technographics
AFCL Bioscience Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by AFCL Bioscience and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 10 AFCL Bioscience employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that AFCL Bioscience has purchased the following applications: GB Network Hosting for Application Hosting and Computing Services in 2023, Imunify360 for Web Application Firewalls (WAF) in 2023 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems AFCL Bioscience is running and its propensity to invest more and deepen its relationship with GB Network Solutions , CloudLinux or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing AFCL Bioscience revenues, which have grown to $2.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for AFCL Bioscience intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
AFCL Bioscience Tech Stack and Enterprise Applications
AFCL Bioscience IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| GB Network Solutions | Legacy | GB Network Hosting | Application Hosting and Computing Services | IaaS | n/a | 2023 | 2023 |
In 2023, AFCL Bioscience implemented GB Network Hosting to provide public website hosting. GB Network Hosting is recorded as the Application for AFCL Bioscience within the Application Hosting and Computing Services category, and the deployment is explicitly used on the company website.
The GB Network Hosting implementation focuses on standard web hosting capabilities common to Application Hosting and Computing Services, including web server provisioning, DNS configuration and cutover, TLS certificate provisioning, managed backups and basic monitoring. Configuration was scaled to match a small organization profile of about 10 employees, emphasizing straightforward content deployment workflows and lightweight hosting resource allocation rather than complex multi-tier infrastructure.
Operational scope is limited to the corporate website and customer facing web properties, impacting marketing and online customer engagement functions. The implementation aligns the GB Network Hosting application with routine website content updates, domain management, and hosted asset delivery, keeping technical operations within a single hosting boundary rather than spanning multiple enterprise systems.
Governance and rollout centered on DNS migration and content publication processes, with administrative account controls and monitoring configured as part of the initial go live. Ongoing operational responsibilities are described through website administration and hosting management tasks, consistent with Application Hosting and Computing Services governance for small scale retail web deployments.
|
AFCL Bioscience CyberSecurity
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| CloudLinux | Legacy | Imunify360 | Web Application Firewalls (WAF) | CyberSecurity | n/a | 2023 | 2023 |
|
IT Decision Makers and Key Stakeholders at AFCL Bioscience
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
Apps Being Evaluated by AFCL Bioscience Executives
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||